{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [["COVID-19", "collaboration", "phytomedicines", "safety", "strategic interventions", "therapeutic management"]], "GeneralNote": [], "OtherAbstract": [], "CitationSubset": [], "SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "PMID": "34191921", "DateRevised": {"Year": "2021", "Month": "07", "Day": "02"}, "Article": {"ArticleDate": [{"Year": "2020", "Month": "08", "Day": "14"}], "Language": ["eng"], "ELocationID": ["1934578X20945086", "10.1177/1934578X20945086"], "Journal": {"ISSN": "1934-578X", "JournalIssue": {"Volume": "15", "Issue": "8", "PubDate": {"Year": "2020", "Month": "Aug"}}, "Title": "Natural product communications", "ISOAbbreviation": "Nat Prod Commun"}, "ArticleTitle": "COVID-19 Pandemic: A Case for Phytomedicines.", "Pagination": {"StartPage": "1934578X20945086", "MedlinePgn": "1934578X20945086"}, "Abstract": {"AbstractText": ["Coronavirus disease 2019 (COVID-19) is an infection caused by a newly discovered coronavirus which was identified in Wuhan, China. The race is on globally to repurpose drugs for COVID-19 and develop a safe and effective vaccine against the disease. There is an urgent need to search for effective remedies against COVID-19 from the rich and extensive flora of Africa and the world. A literature search was conducted to obtain information on drugs with the potential for effectiveness in the treatment of COVID-19 based mostly on outcomes of preclinical studies and a few clinical investigations. This was considered important to this perspective as some of the identified mechanisms of action may be related to potential anti-COVID-19 actions of phytomedicines. The findings from the literature search were also used to establish the need for exploration of phytomedicines in the fight against COVID-19. This perspective identifies the need to preserve the rich tradition of herbal medicine in Africa, repositioning it by inculcating all aspects of discovery, development, and chemical evaluation of pharmaceuticals from medicinal plants for effective management of prevalent diseases. The identified mechanisms of action of current drugs under consideration for the treatment of COVID-19 include preventing fusion of SARS-CoV-2 with human cells; decrease acidity in endosomes, cell membrane-derived vesicles for transportation of the virus within the host cell and within which the virus can replicate; and blockade of the production of proinflammatory cytokines. Phytomedicines may possibly elicit either one or a combination of these effects. The case for the exploration of phytomedicines against COVID-19 is strengthened by the emergence of a number of conventional drugs from medicinal plants and the emergence of botanicals with proven efficacy for some medical conditions. Caution against indiscriminate use of medicinal plants in the guise of treating COVID-19 has been highlighted and the need for reliable preclinical and clinical studies."], "CopyrightInformation": "\u00a9 The Author(s) 2020."}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [], "CollectiveName": "ACEDHARS UNILAG COVID-19 Response Team"}, {"Identifier": ["0000-0002-9007-0437"], "AffiliationInfo": [{"Identifier": ["98002"], "Affiliation": "African Center of Excellence for Drug Research, Herbal Medicine Development and Regulatory Science (ACEDHARS), University of Lagos (UNILAG), Lagos, Nigeria."}, {"Identifier": ["309368"], "Affiliation": "Department of Pharmacology, Therapeutics & Toxicology, Faculty of Basic Medical Sciences, College of Medicine, University of Lagos, Lagos, Nigeria."}], "LastName": "Akindele", "ForeName": "Abidemi J", "Initials": "AJ"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": ["98002"], "Affiliation": "African Center of Excellence for Drug Research, Herbal Medicine Development and Regulatory Science (ACEDHARS), University of Lagos (UNILAG), Lagos, Nigeria."}, {"Identifier": ["70670"], "Affiliation": "Department of Chemistry, Faculty of Science, University of Lagos, Lagos, Nigeria."}], "LastName": "Agunbiade", "ForeName": "Foluso O", "Initials": "FO"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": ["98002"], "Affiliation": "African Center of Excellence for Drug Research, Herbal Medicine Development and Regulatory Science (ACEDHARS), University of Lagos (UNILAG), Lagos, Nigeria."}, {"Identifier": ["70670"], "Affiliation": "Department of Pharmacognosy, Faculty of Pharmacy, University of Lagos, Lagos, Nigeria."}], "LastName": "Sofidiya", "ForeName": "Margaret O", "Initials": "MO"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": ["98002"], "Affiliation": "African Center of Excellence for Drug Research, Herbal Medicine Development and Regulatory Science (ACEDHARS), University of Lagos (UNILAG), Lagos, Nigeria."}, {"Identifier": ["309368"], "Affiliation": "Department of Pharmacology, Therapeutics & Toxicology, Faculty of Basic Medical Sciences, College of Medicine, University of Lagos, Lagos, Nigeria."}], "LastName": "Awodele", "ForeName": "Olufunsho", "Initials": "O"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": ["98002"], "Affiliation": "African Center of Excellence for Drug Research, Herbal Medicine Development and Regulatory Science (ACEDHARS), University of Lagos (UNILAG), Lagos, Nigeria."}, {"Identifier": ["70670"], "Affiliation": "Department of Pharmacognosy, Faculty of Pharmacy, University of Lagos, Lagos, Nigeria."}], "LastName": "Sowemimo", "ForeName": "Abimbola", "Initials": "A"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": ["98002"], "Affiliation": "African Center of Excellence for Drug Research, Herbal Medicine Development and Regulatory Science (ACEDHARS), University of Lagos (UNILAG), Lagos, Nigeria."}, {"Identifier": ["70670"], "Affiliation": "Department of Botany, Faculty of Science, University of Lagos, Lagos, Nigeria."}], "LastName": "Ade-Ademilua", "ForeName": "Omobolanle", "Initials": "O"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": ["98002"], "Affiliation": "African Center of Excellence for Drug Research, Herbal Medicine Development and Regulatory Science (ACEDHARS), University of Lagos (UNILAG), Lagos, Nigeria."}, {"Identifier": ["70670"], "Affiliation": "Department of Pharmaceutical Chemistry, Faculty of Pharmacy, University of Lagos, Lagos, Nigeria."}], "LastName": "Akinleye", "ForeName": "Moshood O", "Initials": "MO"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": ["98002"], "Affiliation": "African Center of Excellence for Drug Research, Herbal Medicine Development and Regulatory Science (ACEDHARS), University of Lagos (UNILAG), Lagos, Nigeria."}, {"Identifier": ["309368"], "Affiliation": "Department of Pharmacology, Therapeutics & Toxicology, Faculty of Basic Medical Sciences, College of Medicine, University of Lagos, Lagos, Nigeria."}], "LastName": "Ishola", "ForeName": "Ismail O", "Initials": "IO"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": ["98002"], "Affiliation": "African Center of Excellence for Drug Research, Herbal Medicine Development and Regulatory Science (ACEDHARS), University of Lagos (UNILAG), Lagos, Nigeria."}, {"Identifier": ["70670"], "Affiliation": "Department of Pharmacognosy, Faculty of Pharmacy, University of Lagos, Lagos, Nigeria."}], "LastName": "Orabueze", "ForeName": "Ifeoma", "Initials": "I"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": ["98002"], "Affiliation": "African Center of Excellence for Drug Research, Herbal Medicine Development and Regulatory Science (ACEDHARS), University of Lagos (UNILAG), Lagos, Nigeria."}, {"Identifier": ["309368"], "Affiliation": "Department of Medical Microbiology & Parasitology, Faculty of Basic Medical Sciences, College of Medicine, University of Lagos, Lagos, Nigeria."}], "LastName": "Salu", "ForeName": "Olumuyiwa B", "Initials": "OB"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": ["98002"], "Affiliation": "African Center of Excellence for Drug Research, Herbal Medicine Development and Regulatory Science (ACEDHARS), University of Lagos (UNILAG), Lagos, Nigeria."}, {"Identifier": ["309368"], "Affiliation": "Department of Pharmacology, Therapeutics & Toxicology, Faculty of Basic Medical Sciences, College of Medicine, University of Lagos, Lagos, Nigeria."}], "LastName": "Oreagba", "ForeName": "Ibrahim A", "Initials": "IA"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": ["98002"], "Affiliation": "African Center of Excellence for Drug Research, Herbal Medicine Development and Regulatory Science (ACEDHARS), University of Lagos (UNILAG), Lagos, Nigeria."}, {"Identifier": ["70670"], "Affiliation": "Department of Chemistry, Faculty of Science, University of Lagos, Lagos, Nigeria."}], "LastName": "Asekun", "ForeName": "Olayinka T", "Initials": "OT"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": ["98002"], "Affiliation": "African Center of Excellence for Drug Research, Herbal Medicine Development and Regulatory Science (ACEDHARS), University of Lagos (UNILAG), Lagos, Nigeria."}, {"Identifier": ["70670"], "Affiliation": "Department of Pharmacognosy, Faculty of Pharmacy, University of Lagos, Lagos, Nigeria."}], "LastName": "Odukoya", "ForeName": "Olukemi", "Initials": "O"}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "United States", "MedlineTA": "Nat Prod Commun", "NlmUniqueID": "101477873", "ISSNLinking": "1555-9475"}, "CoiStatement": "Declaration of Conflicting Interests: The author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article."}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Miller A., Reandelar MJ., Fasciglione K. et al. Correlation between universal BCG vaccination policy and reduced morbidity and mortality for COVID-19: an epidemiological study. medRxiv and bioRxiv. 2020. 10.1101/2020.03.24.20042937", "ArticleIdList": ["10.1101/2020.03.24.20042937"]}, {"Citation": "\nWHO \nBacille Calmette-Gu\u00e9rin (BCG) vaccination and COVID-19. 2020\nAccessed April 15, 2020\nhttps://www.who.int/news-room/commentaries/detail/bacille-calmette-gu%C3%A9rin-%28bcg%29-vaccination-and-covid-19\n"}, {"Citation": "\nNigeria Centre for Disease Control (NCDC) \nUpdates on COVID-19 (Coronavirus Disease 2019): case summary in Nigeria as at april 20th 2020. 2020\nAccessed April 20, 2020\nhttps://covid19.ncdc.gov.ng/\n"}, {"Citation": "Vincent MJ., Bergeron E., Benjannet S. et al.. Chloroquine is a potent inhibitor of SARS coronavirus infection and spread. Virol J. 2005;2:69 10.1186/1743-422X-2-69", "ArticleIdList": ["10.1186/1743-422X-2-69", "PMC1232869", "16115318"]}, {"Citation": "Keyaerts E., Li S., Vijgen L. et al.. Antiviral activity of chloroquine against human coronavirus OC43 infection in newborn mice. Antimicrob Agents Chemother. 2009;53(8):3416-3421.10.1128/AAC.01509-08", "ArticleIdList": ["10.1128/AAC.01509-08", "PMC2715625", "19506054"]}, {"Citation": "\nFrie K., Gbinigie K.\nChloroquine and hydroxychloroquine: current evidence for their effectiveness in treating COVID-19. Center for evidence-based medicine, University of Oxford, Nuffield Department of Primary Care Health Sciences, U.K. 2020\nAccessed April 15, 2020\nhttps://www.cebm.net/covid-19/chloroquine-and-hydroxychloroquine-current-evidence-for-their-effectiveness-in-treating-covid-19/\n"}, {"Citation": "Liu J., Cao R., Xu M. et al.. Hydroxychloroquine, a less toxic derivative of chloroquine, is effective in inhibiting SARS-CoV-2 infection in vitro. Cell Discov. 2020;6:16.10.1038/s41421-020-0156-0", "ArticleIdList": ["10.1038/s41421-020-0156-0", "PMC7078228", "32194981"]}, {"Citation": "Wang M., Cao R., Zhang L. et al.. Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro . Cell Res. 2020;30(3):269-271.10.1038/s41422-020-0282-0", "ArticleIdList": ["10.1038/s41422-020-0282-0", "PMC7054408", "32020029"]}, {"Citation": "Yao X., Ye F., Zhang M. et al. In vitro antiviral activity and projection of optimized dosing design of hydroxychloroquine for the treatment of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2. Clin Infect Dis. 2020;10 10.1093/cid/ciaa237", "ArticleIdList": ["10.1093/cid/ciaa237", "PMC7108130", "32150618"]}, {"Citation": "Gao J., Tian Z., Yang X. Breakthrough: chloroquine phosphate has shown apparent efficacy in treatment of COVID-19 associated pneumonia in clinical studies. Biosci Trends. 2020;14(1):72-73.10.5582/bst.2020.01047", "ArticleIdList": ["10.5582/bst.2020.01047", "32074550"]}, {"Citation": "Gautret P., Lagier J-C., Parola P. et al. Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial. Int J Antimicrob Agents. 2020;56(1):105949 10.1016/j.ijantimicag.2020.105949", "ArticleIdList": ["10.1016/j.ijantimicag.2020.105949", "PMC7102549", "32205204"]}, {"Citation": "Devaux CA., Rolain J-M., Colson P., Raoult D. New insights on the antiviral effects of chloroquine against coronavirus: what to expect for COVID-19? Int J Antimicrob Agents. 2020;55(5):105938 10.1016/j.ijantimicag.2020.105938", "ArticleIdList": ["10.1016/j.ijantimicag.2020.105938", "PMC7118659", "32171740"]}, {"Citation": "Kupferschmidt K., Cohen J. Race to find COVID-19 treatments accelerates. Science. 2020;367(6485):1412-1413.10.1126/science.367.6485.1412", "ArticleIdList": ["10.1126/science.367.6485.1412", "32217705"]}, {"Citation": "Savarino A., Boelaert JR., Cassone A., Majori G., Cauda R. Effects of chloroquine on viral infections: an old drug against today\u2019s diseases? Lancet Infect Dis. 2003;3(11):722-727.10.1016/S1473-3099(03)00806-5", "ArticleIdList": ["10.1016/S1473-3099(03)00806-5", "PMC7128816", "14592603"]}, {"Citation": "\nZhang S.\nThe best hopes for a coronavirus drug. The Atlantic. 2020\nAccessed April 15, 2020\nhttps://www.theatlantic.com/science/archive/2020/04/what-coronavirus-drug-will-look-like/609661/\n"}, {"Citation": "Wagstaff KM., Sivakumaran H., Heaton SM., Harrich D., Jans DA. Ivermectin is a specific inhibitor of importin \u03b1/\u03b2-mediated nuclear import able to inhibit replication of HIV-1 and dengue virus. Biochem J. 2012;443(3):851-856.10.1042/BJ20120150", "ArticleIdList": ["10.1042/BJ20120150", "PMC3327999", "22417684"]}, {"Citation": "Caly L., Druce JD., Catton MG., Jans DA., Wagstaff KM. The FDA-approved drug ivermectin inhibits the replication of SARS-CoV-2 in vitro . Antiviral Res. 2020;178:104787 10.1016/j.antiviral.2020.104787", "ArticleIdList": ["10.1016/j.antiviral.2020.104787", "PMC7129059", "32251768"]}, {"Citation": "Tay MYF., Fraser JE., Chan WKK. et al.. Nuclear localization of dengue virus (DENV) 1-4 non-structural protein 5; protection against all 4 DENV serotypes by the inhibitor ivermectin. Antiviral Res. 2013;99(3):301-306.10.1016/j.antiviral.2013.06.002", "ArticleIdList": ["10.1016/j.antiviral.2013.06.002", "23769930"]}, {"Citation": "Hoffmann M., Kleine-Weber H., Schroeder S. et al.. SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor. Cell. 2020;181(2):271-280.10.1016/j.cell.2020.02.052", "ArticleIdList": ["10.1016/j.cell.2020.02.052", "PMC7102627", "32142651"]}, {"Citation": "Chu CM., Cheng VCC., Hung IFN. et al.. Role of lopinavir/ritonavir in the treatment of SARS: initial virological and clinical findings. Thorax. 2004;59(3):252-256.10.1136/thorax.2003.012658", "ArticleIdList": ["10.1136/thorax.2003.012658", "PMC1746980", "14985565"]}, {"Citation": "Sheahan TP., Sims AC., Leist SR. et al.. Comparative therapeutic efficacy of remdesivir and combination lopinavir, ritonavir, and interferon beta against MERS-CoV. Nat Commun. 2020;11(1):222 10.1038/s41467-019-13940-6", "ArticleIdList": ["10.1038/s41467-019-13940-6", "PMC6954302", "31924756"]}, {"Citation": "Dong L., Hu S., Gao J. Discovering drugs to treat coronavirus disease 2019 (COVID-19). Drug Discov Ther. 2020;14(1):58-60.10.5582/ddt.2020.01012 10.5582/ddt.2020.01012", "ArticleIdList": ["10.5582/ddt.2020.01012", "10.5582/ddt.2020.01012", "32147628"]}, {"Citation": "Furuta Y., Takahashi K., Shiraki K. et al.. T-705 (favipiravir) and related compounds: novel broad-spectrum inhibitors of RNA viral infections. Antiviral Res. 2009;82(3):95-102.10.1016/j.antiviral.2009.02.198", "ArticleIdList": ["10.1016/j.antiviral.2009.02.198", "PMC7127082", "19428599"]}, {"Citation": "Fischer WA., Vetter P., Bausch DG. et al.. Ebola virus disease: an update on post-exposure prophylaxis. Lancet Infect Dis. 2018;18(6):e183-e192.10.1016/S1473-3099(17)30677-1", "ArticleIdList": ["10.1016/S1473-3099(17)30677-1", "PMC6636351", "29153266"]}, {"Citation": "\nAmpel NM.\nFavipiravir: a potential antiviral for COVID-19? NEJM Journal Watch. 2020\nAccessed April 15, 2020\nhttps://www.jwatch.org/na51293/2020/04/09/favipiravir-potential-antiviral-covid-19\n"}, {"Citation": "Thanh Le T., Andreadakis Z., Kumar A. et al.. The COVID-19 vaccine development landscape. Nat Rev Drug Discov. 2020;19(5):305-306.10.1038/d41573-020-00073-5", "ArticleIdList": ["10.1038/d41573-020-00073-5", "32273591"]}, {"Citation": "\nWu C.\nRecent developments of marketing authorization of botanical drugs in the USA. Botanical Review Team, Office of Pharmaceutical Quality, CDER, FDA. 2017\nAccessed April 15, 2020\nhttps://www.bfarm.de/SharedDocs/Downloads/DE/Service/Termine-und-Veranstaltungen/dialogveranstaltungen/dialog_2017/170914/8_Wu.pdf?_blob=publicationFile&v=2\n"}, {"Citation": "\nHurt S.\nSummary of clinical studies into efficacy of GOPO: a key component of Rosa canina. Afrigetics Botanicals. 2019\nAccessed April 15, 2020\nhttps://afrigetics.com/summary-of-clinical-studies-into-efficacy-of-gopo-a-key-component-of-rosa-canina/\n"}, {"Citation": "Cohen M., Rosehip CM. Rosehip - an evidence based herbal medicine for inflammation and arthritis. Aust Fam Physician. 2012;41(7):495-498.", "ArticleIdList": ["22762068"]}, {"Citation": "National Institute for Health Care and Excellence (NICE) Over-the-counter options for osteoarthritis joint pain, reviewing the latest evidence. Clinical guidelines CG. 2014;177"}, {"Citation": "Anonymous Redeploying plant defences. Nat Plants. 2020;6(3):177.10.1038/s41477-020-0628-0", "ArticleIdList": ["10.1038/s41477-020-0628-0", "PMC7091691", "32170291"]}, {"Citation": "Awodele O., Fajemirokun O., Oreagba I. et al. Herbal medicines use: remedies or risks. West Afr J Pharm. 2018;29(2):1-18."}, {"Citation": "WHO The WHO traditional medicine programme: policy and implementation. Int Tradit Med Newsl. 1985;1:1-5."}, {"Citation": "Farnsworth NR., Akerele O., Bingel AS., Soejarto DD., Guo Z., Eno Z. Medicinal plants in therapy. Bull World Health Organ. 1985;63(6):965-981.", "ArticleIdList": ["PMC2536466", "3879679"]}, {"Citation": "Eisenberg DM., Davis RB., Ettner SL. et al.. Trends in alternative medicine use in the United States, 1990-1997: results of a follow-up national survey. JAMA. 1998;280(18):1569-1575.10.1001/jama.280.18.1569", "ArticleIdList": ["10.1001/jama.280.18.1569", "9820257"]}, {"Citation": "Gadano AB., Gurni AA., Carballo MA. Argentine folk medicine: genotoxic effects of Chenopodiaceae family. J Ethnopharmacol. 2006;103(2):246-251.10.1016/j.jep.2005.08.043", "ArticleIdList": ["10.1016/j.jep.2005.08.043", "16219440"]}, {"Citation": "Akintonwa A., Awodele O., Afolayan G., Coker HAB. Mutagenic screening of some commonly used medicinal plants in Nigeria. J Ethnopharmacol. 2009;125(3):461-470.10.1016/j.jep.2009.07.013", "ArticleIdList": ["10.1016/j.jep.2009.07.013", "19619631"]}, {"Citation": "Awodele O., Osunkalu VO., Akinde OR. et al. Modulatory roles of antioxidants against the aqueous stem bark extract of Alstonia boonei (Apocynaceae)-induced nephrotoxicity and testicular damage. Int J Biomed Pharmaceut Sci. 2010;4(2):76-80."}, {"Citation": "Amole OO., Yemitan OK., Oshikoya KA. Anticonvulsant activity of Rauwolfia vomitoria (Afzel). Afr J Pharm Pharmacol. 2009;3(2):319-322."}, {"Citation": "Ilori M., Sheteolu AO., Omonigbehin EA., Adeneye AA. Antidiarrhoeal activities of Ocimum gratissimum (Lamiaceae). J Diarrh Dis Res. 1996;14(4):283-285.", "ArticleIdList": ["9203793"]}, {"Citation": "Oyelami OA., Agbakwuru EA., Adeyemi LA., Adedeji GB. The effectiveness of grapefruit (Citrus paradisi) seeds in treating urinary tract infections. J Altern Complement Med. 2005;11(2):369-371.10.1089/acm.2005.11.369", "ArticleIdList": ["10.1089/acm.2005.11.369", "15865506"]}], "ReferenceList": []}], "History": [{"Year": "2020", "Month": "5", "Day": "27"}, {"Year": "2020", "Month": "6", "Day": "28"}, {"Year": "2021", "Month": "6", "Day": "30", "Hour": "17", "Minute": "28"}, {"Year": "2021", "Month": "7", "Day": "1", "Hour": "6", "Minute": "0"}, {"Year": "2021", "Month": "7", "Day": "1", "Hour": "6", "Minute": "1"}, {"Year": "2020", "Month": "8", "Day": "17"}], "PublicationStatus": "epublish", "ArticleIdList": ["34191921", "PMC7429914", "10.1177/1934578X20945086", "10.1177_1934578X20945086"]}}], "PubmedBookArticle": []}